Pharma Journalist -

AstraZeneca and MedImmune announced high-level results from the Phase III ARCTIC trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who have…
Read More...

AMRI will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities in Europe with the addition of the Bruker AVANCE NEO 600 MHz NMR Spectrometer. “NMR is a core…
Read More...

Grand River Aseptic Manufacturing has announced its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN…
Read More...

Zymeworks Inc. announced that Celgene Corporation has exercised its right to expand its collaboration agreement for the research, development, and commercialization of bispecific…
Read More...

Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.…
Read More...

Q Therapeutics and REPROCELL announced the formation of MAGiQ Therapeutics, Inc., a Japanese joint venture company. MAGiQ will develop iPSC-derived, glial-restricted progenitor cells…
Read More...

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.  Advent’s…
Read More...

NovaDigm Therapeutics announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of…
Read More...

Phoenix Molecular Designs (PhoenixMD) announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026…
Read More...

Sinovac Biotech Ltd. announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine developed by Sinovac Biotech on the unblinding conference held on…
Read More...